Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009.

RATIONALE The incidence of influenza-associated acute respiratory failure is unknown. OBJECTIVES To estimate the population-based incidence of influenza-associated acute respiratory failure hospitalizations. METHODS This is a cohort study from January 2003 through March 2009 using hospitalization databases for Arizona, California, and Washington from the Healthcare Cost and Utilization Project and influenza surveillance data for regions encompassing these states. Acute respiratory failure requiring mechanical ventilation was defined by International Classification of Diseases-9-CM code. We used negative-binomial regression modeling to estimate the incidence of influenza-associated events. MEASUREMENTS AND MAIN RESULTS The incidence of influenza-associated acute respiratory failure was 2.7 per 100,000 person-years (95% confidence interval, 0.2-23.5), and during the influenza season, 3.8% of all respiratory failure hospitalizations were attributable to influenza. Compared with adults aged 18-49 years, the incidence rate ratio for influenza-associated acute respiratory failure was lower among children aged 1-4 (0.9) and 5-17 years (0.3); however, it was higher among adults aged 50-64 (4.8), 65-74 (10.4), 75-84 (19.9), and 85 years and older (33.7). Results were similar with more sensitive and specific outcome definitions and in a sensitivity analysis using only Arizona-specific outcome and surveillance data. CONCLUSIONS Our data indicate that influenza was an important contributor to respiratory failure hospitalizations during 2003-2009. Clinicians should maintain a high index of suspicion for influenza among hospitalized patients with acute respiratory illness when influenza is circulating in a community. Influenza has a greater effect on respiratory failure in the elderly, for whom better prevention measures are needed.

[1]  S. Wisniewski,et al.  Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013 , 2013, MMWR. Morbidity and mortality weekly report.

[2]  D. Fleming,et al.  Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[4]  A. Arnedo-Pena,et al.  Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study , 2012, Vaccine.

[5]  K. Edwards,et al.  Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. , 2012, The Journal of infectious diseases.

[6]  Hong Zhou,et al.  Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Goss,et al.  Population-Based Incidence Of Influenza-Associated Respiratory Failure Hospitalizations In The US West Coast, 2003 To 2008 , 2012, ATS 2012.

[8]  M. Levin,et al.  The rationale for quadrivalent influenza vaccines , 2012, Human vaccines & immunotherapeutics.

[9]  Jiaquan Xu,et al.  Deaths: final data for 2009. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[10]  C. Goss,et al.  Monitoring Influenza Activity in the United States: A Comparison of Traditional Surveillance Systems with Google Flu Trends , 2011, PloS one.

[11]  Kwok-Hung Chan,et al.  Validation of Statistical Models for Estimating Hospitalization Associated with Influenza and Other Respiratory Viruses , 2011, PloS one.

[12]  Qingxia Chen,et al.  Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. , 2011, The Journal of infectious diseases.

[13]  L. Gubareva,et al.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  W. Schaffner,et al.  Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. , 2010, The Journal of pediatrics.

[15]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[16]  D. Fleming,et al.  Fatal Cases of Influenza A in Childhood , 2009, PloS one.

[17]  Bruce Fireman,et al.  Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias , 2009, American journal of epidemiology.

[18]  Jeremy Ginsberg,et al.  Detecting influenza epidemics using search engine query data , 2009, Nature.

[19]  A. Podda,et al.  MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis , 2008, Influenza and other respiratory viruses.

[20]  T. Murphy,et al.  Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. , 2007, JAMA.

[21]  J. Nelson,et al.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors. , 2006, International journal of epidemiology.

[22]  Keiji Fukuda,et al.  Influenza-associated deaths among children in the United States, 2003-2004. , 2005, The New England journal of medicine.

[23]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[24]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[25]  K. Lewandowski Contributions to the epidemiology of acute respiratory failure , 2003, Critical care.

[26]  C. Behrendt Clinical Investigations in Critical CareAcute Respiratory Failure in the United States: Incidence and 31-Day Survival , 2000 .

[27]  Kristian Antonsen,et al.  Incidence and Mortality after Acute Respiratory Failure and Acute Respiratory Distress Syndrome in Sweden, Denmark, and Iceland , 1999 .

[28]  Nicholas S. Kelley,et al.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[29]  Erin Burns,et al.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. , 2010, MMWR. Morbidity and mortality weekly report.